Matches in Nanopublications for { ?s ?p "[In the current pilot study, BC with p16 gene hypermethylation had a lower risk of recurrence after treatment with IL-2, as compared to IL-2 treated BC without p16 hypermethylation (p = 0.02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP173763.RAa3xm-6ClNwJsVz6fOcuc3mgjhBw7IpmtGCckXmeHOJ8130_assertion description "[In the current pilot study, BC with p16 gene hypermethylation had a lower risk of recurrence after treatment with IL-2, as compared to IL-2 treated BC without p16 hypermethylation (p = 0.02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP173763.RAa3xm-6ClNwJsVz6fOcuc3mgjhBw7IpmtGCckXmeHOJ8130_provenance.
- NP299499.RAkPsGp-Ril-bE9KSy-VFaIjoa__NAr69TpgyFwXrdD8Y130_assertion description "[In the current pilot study, BC with p16 gene hypermethylation had a lower risk of recurrence after treatment with IL-2, as compared to IL-2 treated BC without p16 hypermethylation (p = 0.02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP299499.RAkPsGp-Ril-bE9KSy-VFaIjoa__NAr69TpgyFwXrdD8Y130_provenance.
- NP304233.RAdEA72EquRZuxkZV9P9PckUqp8XjndvvtTYv2NyIu5-8130_assertion description "[In the current pilot study, BC with p16 gene hypermethylation had a lower risk of recurrence after treatment with IL-2, as compared to IL-2 treated BC without p16 hypermethylation (p = 0.02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304233.RAdEA72EquRZuxkZV9P9PckUqp8XjndvvtTYv2NyIu5-8130_provenance.
- NP306329.RATHrBZkhs8MFDoHW0keKsNpDs0r0X6v7zbcsWuUcEBE4130_assertion description "[In the current pilot study, BC with p16 gene hypermethylation had a lower risk of recurrence after treatment with IL-2, as compared to IL-2 treated BC without p16 hypermethylation (p = 0.02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306329.RATHrBZkhs8MFDoHW0keKsNpDs0r0X6v7zbcsWuUcEBE4130_provenance.
- assertion description "[In the current pilot study, BC with p16 gene hypermethylation had a lower risk of recurrence after treatment with IL-2, as compared to IL-2 treated BC without p16 hypermethylation (p = 0.02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In the current pilot study, BC with p16 gene hypermethylation had a lower risk of recurrence after treatment with IL-2, as compared to IL-2 treated BC without p16 hypermethylation (p = 0.02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In the current pilot study, BC with p16 gene hypermethylation had a lower risk of recurrence after treatment with IL-2, as compared to IL-2 treated BC without p16 hypermethylation (p = 0.02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP776713.RA7PWNL3l3NzJ_7Whz6_DC0TYowp5G-Sxfkt1aH977Bc4130_assertion description "[In the current pilot study, BC with p16 gene hypermethylation had a lower risk of recurrence after treatment with IL-2, as compared to IL-2 treated BC without p16 hypermethylation (p = 0.02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776713.RA7PWNL3l3NzJ_7Whz6_DC0TYowp5G-Sxfkt1aH977Bc4130_provenance.
- NP776712.RAQIlykIBXv1JHCtfmSdLBG1Wm7wsjzVLA4_jV6Fn-utQ130_assertion description "[In the current pilot study, BC with p16 gene hypermethylation had a lower risk of recurrence after treatment with IL-2, as compared to IL-2 treated BC without p16 hypermethylation (p = 0.02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776712.RAQIlykIBXv1JHCtfmSdLBG1Wm7wsjzVLA4_jV6Fn-utQ130_provenance.
- NP493216.RAonmVvk_O2qiZLWXGempdEh2DfyYk0hkhXBA-F3LcCoY130_assertion description "[In the current pilot study, BC with p16 gene hypermethylation had a lower risk of recurrence after treatment with IL-2, as compared to IL-2 treated BC without p16 hypermethylation (p = 0.02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493216.RAonmVvk_O2qiZLWXGempdEh2DfyYk0hkhXBA-F3LcCoY130_provenance.